Glycemic Thresholds for Diabetes-Specific Retinopathy
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 26 of the 26 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To re-evaluate the relationship between glycemia and diabetic retinopathy. RESEARCH DESIGN AND METHODS: We conducted a data-pooling analysis of nine studies from five countries with 44,623 participants aged 20–79 years with gradable retinal photographs. The relationship between diabetes-specific retinopathy (defined as moderate or more severe retinopathy) and three glycemic measures (fasting plasma glucose [FPG; n = 41,411], 2-h post oral glucose load plasma glucose [2-h PG; n = 21,334], and A1C [n = 28,010]) was examined. RESULTS: When diabetes-specific retinopathy was plotted against continuous glycemic measures, a curvilinear relationship was observed for FPG and A1C. Diabetes-specific retinopathy prevalence was low for FPG <6.0 mmol/l and A1C <6.0% but increased above these levels. Based on vigintile (20 groups with equal numbers) distributions, glycemic thresholds for diabetes-specific retinopathy were observed over the range of 6.4–6.8 mmol/l for FPG, 9.8–10.6 mmol/l for 2-h PG, and 6.3–6.7% for A1C. Thresholds for diabetes-specific retinopathy from receiver-operating characteristic curve analyses were 6.6 mmol/l for FPG, 13.0 mmol/l for 2-h PG, and 6.4% for A1C. CONCLUSIONS: This study broadens the evidence based on diabetes diagnostic criteria. A narrow threshold range for diabetes-specific retinopathy was identified for FPG and A1C but not for 2-h PG. The combined analyses suggest that the current diabetes diagnostic level for FPG could be lowered to 6.5 mmol/l and that an A1C of 6.5% is a suitable alternative diagnostic criterion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, evidence indicates that HbA1c, or fasting glucose, are stronger predictors of vascular complications than 2 h OGTT and it is therefore best to adopt these simple measures for general screening, particularly given their high reproducibility.[35][36][37][38]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38012-9 · Cited by 2,048
Unwin, N. C. (2006) · Cited by 1,661
Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006
Cowie, C. C., Rust, K. F., Ford, E. S., Eberhardt, M. S., Byrd-Holt, D. D., Li, C., Williams, D. E., Gregg, E. W., Bainbridge, K. E., Saydah, S. H., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1296 · Cited by 1,154 · cited 1×
“This has been an ongoing issue with the current diagnostic criteria whereby using FPG alone or an OGTT to diagnose diabetes, give different diabetes prevalence (23).”
BackgroundDiabetic Retinopathy in a Multi-ethnic Cohort in the United States
Wong, T. Y., Klein, R., Islam, F. M. A., Cotch, M. F., Folsom, A. R., Klein, B. E. K., Sharrett, A. R., & Shea, S. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.08.063 · Cited by 684 · cited 1×
“All nine studies measured plasma glucose, and six studies that measured A1C used high-performance liquid chromatography, of which five used a Diabetes Control and Complicat ions Trial (DCCT)-aligned assay (5,12,14,15,18).”
MethodSelf-citationMcCane, D. R., Hanson, R. L., Charles, M. A., Jacobsson, L. T. H., Pettitt, D. D., Bennett, P. H., & Knowler, W. C. (1994) · BMJ · doi:10.1136/bmj.308.6940.1323 · Cited by 484
Harris, M. I., Klein, R., Cowie, C. C., Rowland, M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1230 · Cited by 401 · cited 2×
“All nine studies measured plasma glucose, and six studies that measured A1C used high-performance liquid chromatography, of which five used a Diabetes Control and Complicat ions Trial (DCCT)-aligned assay (5,12,14,15,18).”
BackgroundMethod
Research works printed but not linked: 2
- Colagiuri, 2003, DETECT-2: early detection of type 2 diabetes and IGT, Diabetes Voice, 48, 11
- Diabetic Retinopathy Study Research Group, 1981, Report 7. A modification of the Airlie House classification of diabetic retinopathy, Invest Ophthalmol Vis Sci, 21, 210
Cited by
Items 201–300 of 342
Cichosz, S. L., Johansen, M. D., Ejskjær, N., Hansen, T. K., & Hejlesen, O. K. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12130 · Cited by 6
“showed in a large data-pooling analysis that the association of FPG, OGTT, HbA1c, and retinopathy was similar between measures in relative numbers.(18) In absolute quantities, OGTT screening diagnoses more patients, also identifying most patients diagnosed from HbA1c and FPG screening.”
ResultFlorkowski, C. M., Crooke, M. J., & Reed, M. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.10.009 · Cited by 6
Yu, L. J., Chen, D., Cui, J., Zhong, X., Yang, G.-R., Niu, M.-J., & Yang, J. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0137-3 · Cited by 6
Classification and Laboratory Diagnosis of Diabetes Mellitus
Hare, M. J. L., & Topliss, D. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_28 · Cited by 6
Schulze, M. B., & Hu, F. B. (2022) · Springer eBooks · doi:10.1007/978-1-4614-6625-3_66-1 · Cited by 6
Linee guida ESC 2023 per il trattamento delle malattie cardiovascolari nei pazienti diabetici
Marx, N., Federici, M., Schütt, K. S., Müller‐Wieland, D., Ajjan, R., Antunes, M. J., Christodorescu, R., Crawford, C. A., Angelantonio, E. D., Eliasson, B., et al. (2024) · Giornale Ialiano di Cardiologia · doi:10.1714/4162.41558 · Cited by 6
Is hemoglobin A1c an accurate measure of glycemic control in all diabetic patients?
Bazerbachi, F., Nazarian, S., Alraiyes, A. H., & Alraies, M. C. (2014) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.81a.13147 · Cited by 6
Neuropathy in Prediabetes and the Metabolic Syndrome
Vinik, A. I., & Névoret, M.-L. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3314-9_8 · Cited by 6
HbA1c – ein Alleskönner? Therapiekontrolle, Screening und Diagnose des Diabetes
Landgraf, R., Kowall, B., & Rathmann, W. (2011) · Der Diabetologe · doi:10.1007/s11428-011-0739-3 · Cited by 6
“Die Festlegung des HbA1c auf einen Schwellenwert von ≥6,5% beruht ausschließlich auf epidemiologischen Daten zur moderaten nichtproliferativen Retinopathie – also einer mikrovaskulären Folgekrankheit des Diabetes [5, 18].”
BackgroundToulis, K. A., Jiang, C. Q., Hemming, K., Nirantharakumar, K., Cheng, K. K., Lam, T. H., & Thomas, G. N. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.06.001 · Cited by 6
Manzarbeita, J. (2017) · Wiley eBooks · doi:10.1002/9781118954621.ch4 · Cited by 6
Clinical study on association of diabetic retinopathy severity with HbA1c level
Sharma, P. K., Kumar, K., Dubey, A., Kushwaha, N., & Maravi, P. (2024) · Indian Journal of Clinical and Experimental Ophthalmology · doi:10.18231/j.ijceo.2024.045 · Cited by 5
Villasmil, M. G. P., Ryckman, K. K., Norris, A. W., & Pinnaro, C. T. (2023) · Hormone Research in Paediatrics · doi:10.1159/000534371 · Cited by 5
A Review: Assessment of Hba1c as A Diagnostic Tool in Diabetes Mellitus
AshiqurRahman, M., Islam, S. T., Al-AminHossen, M., Mia, M., & Ferdous, K. (2023) · Molecular Mechanism Research · doi:10.59429/mmr.v1i1.136 · Cited by 5
Using nephropathy as an outcome to determine the HbA1c diagnostic threshold for type 2 diabetes
Butler, A. E., Hunt, S. C., & Kilpatrick, E. S. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103005 · Cited by 5
Goldstein, A., Ding, K., Carrasquillo, O., Levine, B. S., Hasan, A., & Levine, J. (2024) · Ophthalmic and Physiological Optics · doi:10.1111/opo.13363 · Cited by 5
“…eGFR, Estimated Glomerular Filtration Rate; HbA1c, Haemoglobin A1c; NHB, Non-Hispanic Black. between 6.3% and 6.7% for the development of any DR. 50 In contrast, the present investigation identified a higher combined prevalence of retinopathy (27.4%), including 18.7% with NPDR and 8.7% with PDR.”
InfluentialGlycaemic indices and haemoglobin A1c as predictors for non-healing ulcers
Moore, K. J., Dunn, E. C., Marcus, E. N., & Koru‐Sengul, T. (2018) · Journal of Wound Care · doi:10.12968/jowc.2018.27.sup4.s6 · Cited by 5
Diagnostic Criteria and Classification
Lee, C., & Colagiuri, S. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_3 · Cited by 5
Self-citationDiagnosing diabetes mellitus — best practices still unclear
Nathan, D. M. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0072-7 · Cited by 5
Pedersen, Z. O., Jacobsen, S. S., Ewers, B., & Grabowski, D. (2024) · Nutrients · doi:10.3390/nu16111618 · Cited by 4
Consequences and comorbidities associated with obesity
Ghouri, N., Clifton, P. M., Craigie, A. M., Anderson, A. S., Christensen, P., Waters, L., Williams, C., Coco, G. L., & Ricciardelli, L. A. (2017) · Wiley eBooks · doi:10.1002/9781118857991.ch2 · Cited by 4
Diabetes Mellitus Disclosure: A Comprehensive Review on a Global Issue
Atique, R., Saeed, H. A., Haidar, A., Talib, A., Naveed, A., Sharif, J., Shah, R. R., Fatima, H. R., Rana, T., & Anwar, B. (2024) · Global Journal of Multidisciplinary Sciences and Arts · doi:10.70445/gjmdsa.1.1.2024.49-84 · Cited by 4
Diagnosis of Prediabetes and Diabetes Prevention
Buysschaert, M., & Bergman, M. (2013) · Wiley eBooks · doi:10.1002/9781118661321.ch3 · Cited by 4
Research of gestational diabetes mellitus risk evaluation method
Chi, Z., Zhang, S., Wang, Y., Yang, L., Yang, Y., & Li, X. (2016) · Technology and Health Care · doi:10.3233/thc-161174 · Cited by 4
Fiorentino, T. V., Suraci, E., Vito, F. D., Cimellaro, A., Hribal, M. L., Sciacqua, A., Andreozzi, F., Luzza, F., & Sesti, G. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109094 · Cited by 4
Mathematical model for assessing glycemic control in type 2 diabetes mellitus
Misquith, A., Rangareddy, H., Chikkanarayanappa, V., Sultana, A., & Ashakiran, S. (2024) · Bioinformation · doi:10.6026/973206300200116 · Cited by 4
Diagnostic criteria for diabetes in China: are we pushing too much beyond evidence?
Ma, X., Zhang, Y., Ji, Q., Xing, Y., Pan, H., Chen, S., Tang, J.-L., & Zhu, S. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.51 · Cited by 4
Farmer, A. A. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch27 · Cited by 4
Omech, B., Jose-Gaby, T., Amone‐P’Olak, K., Julius, M., Tsima, B. M., & Nkomazana, O. (2017) · Journal of Diabetes and Endocrinology · doi:10.5897/jde2016.0102 · Cited by 4
“The current diagnostic threshold of ≥6.5% was based on a similar relationship with prevalent retinopathy as that of both fasting plasma glucose and 2- h OGTT (Committee, 2009; Colagiuri et al., 2011).”
MethodInfluentialInooka, T., Kominami, T., Yasuda, S., Koyanagi, Y., Ota, J., Okado, S., Tomita, R., Ito, Y., Iwase, T., Terasaki, H., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284686 · Cited by 3
Lee, O., Lim, C.-S., Yoon, S. J., Jung, J. H., Shin, S. H., Heo, J. S., Shin, Y. C., Jung, W., & Han, I. W. (2022) · Biomedicines · doi:10.3390/biomedicines10102427 · Cited by 3
Overgaard, K. S., Andersen, T. R., Mohamed, R. A., Heinsen, L. J., Binderup, H. G., Möller, S., Auscher, S., Lambrechtsen, J., & Egstrup, K. (2023) · Diabetes and Vascular Disease Research · doi:10.1177/14791641231179870 · Cited by 3
Ji, L., Zhi, X., Lu, J., Guo, X., Yang, W., Jia, W., Zou, D., Zhou, Z., Ji, Q., Zhu, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103507 · Cited by 3
Fallstricke bei der Diabetesdiagnostik: Wird zu lax mit Laborwerten umgegangen?
Landgraf, R., Nauck, M. A., Freckmann, G., Müller, U. A., Heinemann, L., Kellerer, M., & Müller‐Wieland, D. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/a-0762-8219 · Cited by 3
Sachin, L. S., Chary, R. N., Pallerla, P., & Prabhakar, S. (2018) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.8195 · Cited by 3
Pharmacist-Managed Diabetic Retinopathy in Hispanic/LatinX Population
Patel, J. S., Gonzalvo, J. D., Eckert, G. J., Schmelz, A. N., & Bhatwadekar, A. D. (2022) · Journal of Pharmacy Practice · doi:10.1177/08971900221136897 · Cited by 3
Diagnosing Diabetes with Hemoglobin A1c: Current Debates and Considerations for Anemic Patients
Kim, T. H., & Choi, S. H. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.5.340 · Cited by 3
Non-insulin therapies in addition to insulin in Type 1 DM treatment
Llano, A., & McKay, G. A. (2020) · British Medical Bulletin · doi:10.1093/bmb/ldaa011 · Cited by 3
Lau, C. S., Lim, M., Hoo, S. P., Gan, C., & Aw, T. C. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaa154 · Cited by 3
Genezing van diabetes mellitus type 2?
Huls, M., van Dijk, M., & Boesten, M. (2013) · Huisarts en Wetenschap · doi:10.1007/s12445-013-0040-3 · Cited by 3
Davies, P. H. O., Chellamuthu, P., & Patel, V. (2010) · The British Journal of Diabetes · doi:10.1177/1474651410394258 · Cited by 3
Will ‘Computable’ Clinical Guidelines Be Compatible with Personalised Care?
Dowie, J., Kaltoft, M. K., & Rajput, V. K. (2024) · Studies in health technology and informatics · doi:10.3233/shti240036 · Cited by 2
Epidemiology, Risk Factors, and Pathophysiology of Diabetic Retinopathy
Bhagat, N., & Zarbin, M. A. (2014) · Springer eBooks · doi:10.1007/978-3-642-54503-0_1 · Cited by 2
Diagnosing diabetes: a new paradigm
Lee, R., & Chowdhury, T. A. (2012) · QJM · doi:10.1093/qjmed/hcs082 · Cited by 2
Hong, S., Kang, J. G., Kim, C. S., Lee, S. J., Park, C., Lee, C. B., & Ihm, S. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.2.167 · Cited by 2
Self-citationLearning about diabetes through epidemiology
Balkau, B., & Holt, R. I. G. (2019) · Diabetic Medicine · doi:10.1111/dme.14120 · Cited by 2
Self-citationDiabetic Retinopathy – Clinical
Bandello, F. M., Lattanzio, R., Marchese, A., & Aragona, E. (2020) · Wiley eBooks · doi:10.1002/9781119309642.ch5 · Cited by 2
Définition, classification et diagnostic du diabète, du prédiabète et du syndrome métabolique
(2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.03.405 · Cited by 2
Wang, J., Ho, P. W., Nandurkar, H. H., & Lim, H. Y. (2024) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-024-02975-2 · Cited by 2
Initial Diagnosis and Management of Type 2 Diabetes Mellitus
Suda, N., & Lee, H. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-84367-0_39 · Cited by 2
Evaluation of a New Point-of-Care HbA1c Assay: The Pixotest
(2019) · International Journal of Clinical Chemistry and Laboratory Medicine · doi:10.20431/2455-7153.0504001 · Cited by 2
Steichen, O., Ranque, B., & Grenier, B. (2013) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(13)51158-6 · Cited by 2
Changing sedentary behaviour in the workplace
Brierley, M. L. (2020) · University of Bedfordshire Repository (University of Bedfordshire) · Cited by 2
Ji, B., Yao, T., Tong, J., Ye, Z., Ping, F., Chen, F., & Liu, X. (2023) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2023.2766 · Cited by 1
Diabetes and the Retina: The Role of Medical Treatment
Bloomgarden, Z. R. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70185 · Cited by 1
Prädiabetes: differenzierte Betrachtung von Subtypen, Risiken und Pathomechanismen
Prystupa, K., & Wagner, R. J. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01203-y · Cited by 1
Taherian, M. R., Etemad, K., Sadeghi, S., Jorjani, G., & Nazari, S. S. H. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/8029111 · Cited by 1
The Line-Drawing Problem and Risk-Based Conditions
Binney, N. (2025) · Springer eBooks · doi:10.1007/978-94-024-2252-8_116 · Cited by 1
V-Go Insulin Delivery Device: A New Tool for Primary Care Settings
Krichten, C. M., Kapustin, J. F., Ghabranious, M., & Mewborn, A. (2015) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2014.09.005 · Cited by 1
Heydari‐Zarnagh, H., Nejatshokouhi, A., & Haghighi, L. (2014) · Zahedan Journal of Research in Medical Sciences · Cited by 1
Chandalia, H. B., & Thadani, P. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0467-8 · Cited by 1
The Role of HbA1C for Diagnosis of Type-2 Diabetes Mellitus - A Review
Zabeen, S., & Akhter, S. R. (2016) · Faridpur Medical College Journal · doi:10.3329/fmcj.v11i1.30877 · Cited by 1
Wenclewska, S., & Drzewoski, J. (2014) · Clinical Diabetology · Cited by 1
Soori, H., Mohammadi, M., & Lebni, J. Y. (2019) · Health Education and Health Promotion · doi:10.29252/hehp.7.2.89 · Cited by 1
Blanchard, A. K. Y., Agbo Adouko Edit, H., Casimir, K. A., Diabagate, H. M. F., Jacques, H. M., & Kouakou, B. (2019) · Universal Journal of Public Health · doi:10.13189/ujph.2019.070601 · Cited by 1
P, D. J., N, D. P. K., A, V. M., & A, R. (2020) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2020.v13i3.36672 · Cited by 1
GANGGUAN PENGHIDU SEBAGAI FAKTOR RISIKO PENURUNAN FUNGSI KOGNITIF PADA LANSIA PENDIDIKAN RENDAH
Turana, Y. (2020) · Majalah Kedokteran Neurosains Perhimpunan Dokter Spesialis Saraf Indonesia · doi:10.52386/neurona.v37i1.95 · Cited by 1
Diagnostic Criteria and Classification
Lee, C., & Colagiuri, S. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_3-1 · Cited by 1
Self-citationStudy of Serum Betatrophin Level in The Patients of Type 2 Diabetes Mellitus
El-Ghandour, A. H., El-Bendary, A. S., Shahba, A., & Soliman, G. A. (2019) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2019.28682 · Cited by 1
ŞANİBAŞ, A. V., Çakmak, F., BAYDAR, İ., & BİNİCİ, D. N. (2023) · New Trends in Medicine Sciences · doi:10.56766/ntms.1161735 · Cited by 1
“In addition, the mean HbA1C value of the combined IFG+IGT group was statistically significantly higher compared to the normal and IGT groups.”
BackgroundInfluentialSpringhorn, C. (2012) · SUNScholar (Stellenbosch University) · Cited by 1
Postnatal testing following gestational diabetes – Authors' reply
Venkataraman, H., Sattar, N. A., & Saravanan, P. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00321-6 · Cited by 1
Sadjadi, R. (2021) · Preprints.org · doi:10.20944/preprints202108.0030.v1 · Cited by 1
“hypertension in diabetes patients, which lead to subsequent microvascular complications (82, 88).”
BackgroundSavadatti, S. S. (2015) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/3wwp-hzsp · Cited by 1
Engström, A. (2026) · doi:10.69622/31819498 · Cited by 1
Is Prediabetes a Risk Factor or is it a Disease?
Muthusamy, K., & Vella, A. V. (2011) · Wiley eBooks · doi:10.1002/9781444340280.ch1
Leósdóttir, M. (2012) · Lund University Publications (Lund University)
Protocolo sobre manejo de la diabetes mellitus tipo 2
Loiola, P. E., Loiola, P. E., Agirre, A. E., Idarreta, I., Gea, L. B., Baquedano, M. M., Asumendi, P. D., Canibe, I. V., & Etxeandia‐Ikobaltzeta, I. (2015) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2015.04.002
Kan diabetes mellitus type 2 genezen?
Huls, M., van Dijk, M., & Boesten, M. (2015) · TvPO · doi:10.1007/s12503-015-0081-0
Diabetes eye care in Norwegian optometric practice
Sundling, V. (2013) · NVA (Nasjonalt vitenarkiv)
Insuliinihoitoinen diabeetikko fysioterapeutin asiakkaana
Härkönen, J., Kosonen, N., & Ruottinen, M. (2013) · Theseus (Ammattikorkeakoulujen)
Wie kriegt man das Gefäßrisiko in den Griff?
Stirban, O. A., & Tschöpe, D. (2015) · Info Diabetologie · doi:10.1007/s15034-015-0499-z
Ethnic differences in gestational diabetes : impact on South Asians
Venkataraman, H. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33723712
The use of glucose measurements to improve screening for diabetes in clinical practice
Nicholls, A. R., Böhning, D., Holt, R. I. G., & Sharp, P. S. (2016) · British Journal of Diabetes · doi:10.15277/bjd.2016.090
The Dilemma of Diagnosing Type-2 Diabetes Mellitus [T2DM] in Overweight Children and Adolescents
Babar, G., Broussard, J., Dai, H. D., & Ugrasbul, F. (2015) · International Journal of Sciences: Basic and Applied Research
Complications in cystic fibrosis-related diabetes
Choudhury, M. (2017) · ORCA Online Research @Cardiff (Cardiff University)
Assessment of putative risk factors in the development of Diabetic Retinopathy in Wales
Chowdhury, S. R. (2016) · ORCA Online Research @Cardiff (Cardiff University)
Bakides, S., Nino, K., & Sakellariadis, G. (2017) · Universal Journal of Public Health · doi:10.13189/ujph.2017.050502
“More than 10 diabetes risk assessment tools have been developed world-wide, [8-19].”
BackgroundImmune cell phenotype and function : impact of type 2 diabetes, obesity, and exercise
Barry, J. (2018) · cIRcle (University of British Columbia) · doi:10.14288/1.0362080
“on glycemic levels that are associated with increased risk of diabetes-specific microvascular complications, with particular focus on retinopathy [5, 6].”
Background11th Annual Symposium on Self-Monitoring of Blood Glucose: April 12–14, 2018, Oslo, Norway
Parkin, C. G., Homberg, A., & Hinzmann, R. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0284
Shephard, M. D. S., Motta, L., Spaeth, B., Halls, H. J., & Duckworth, L. C. (2019) · Wiley eBooks · doi:10.1002/9781119282686.ch16
Elección de una prueba diagnóstica
Steichen, O., & Ranque, B. (2020) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(20)43828-0
Singh, A. K., & Kumar, H. (2020) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/3030107
Malthus, S. (2019) · Massey Research Online (Massey University)
Ray, S. L., Coulson, D. J., Yeoh, M. L. Y., Bakhashab, S., Tamara, A., Latief, J. S., & Weaver, J. U. (2020) · doi:10.21203/rs.3.rs-31267/v1
Commentary: Predictors of development and progression of diabetic retinopathy: A precis
Moharana, B., Gautam, M., & Sharma, B. B. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_2213_21
КРИТЕРИИ ДИАГНОСТИКИ ПРЕДИАБЕТА У ДЕТЕЙ И ПОДРОСТКОВ С ОЖИРЕНИЕМ: ОБЗОР ЛИТЕРАТУРЫ
Толстикова, Е. (2018) · Научный взгляд в будущее · doi:10.30888/2415-7538.2021-22-01-032
The Authors’ Reply: HbA1c Is Insensitive at Month 3 After Kidney Transplantation
Eide, I. A., Halden, T. A. S., & Jenssen, T. G. (2015) · Transplantation · doi:10.1097/tp.0000000000000684
Metadata
- Authors
- Colagiuri, S., Lee, C. M. Y., Wong, T. Y., Balkau, B., Shaw, J. E., Borch-Johnsen, K., & the DETECT-2 Collaboration Writing Group
- Affiliations
- The University of Sydney (AU)
- The University of Melbourne (AU)
- Université Paris-Sud (FR)
- Baker Heart and Diabetes Institute (AU)
- Steno Diabetes Center, Gentofte, Denmark;
- Corresponding author
- Colagiuri, Stephen
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-10-26
- Volume
- 34
- Issue
- 1
- Pages
- 145-150
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3005450
- OpenAlex
- W2134739555
- Cited by
- 300
- References
- 26
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 18 · 2023: 18 · 2022: 21 · 2021: 20 · 2020: 21 · 2019: 13 · 2018: 23 · 2017: 12 · 2016: 23 · 2015: 26 · 2014: 25 · 2013: 30 · 2012: 20
- FWCI
- 21.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- National University of Singapore (submittedVersion)
- eSpace (Curtin University) (submittedVersion)
- Figshare (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Diabetes Australia Research Trust
- National Institutes of Health (n01hc55021-47-0-1, n01hc55020-39-0-0, n01hc55016-37-0-0, n01hc055022-024, n01hc55019-35-0-1, n01hc55018-38-0-1, n01hc55015-48-0-1)
- National Health and Medical Research Council
- National Heart, Lung, and Blood Institute (N01-HC55022, N01 HC055016, N01-HC-55018, N01 HC 55020, N01 HC 55019, N01 HC055020, N01 HC055018, N01-HC55016, N01 HC055022, N01 HC055019, N01‐HC‐55015, N01-HC55021, N01 HC055021, N01 HC055015)
- National Eye Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- diabetic retinopathy, glycemic thresholds, fasting blood glucose, 2-hour postprandial glucose, HbA1c, diabetes diagnostic criteria, glycemic control, fundus images
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetic Retinopathy, Fasting, Glycated Hemoglobin, Humans, Middle Aged, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.